Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wise

Showing results (321-330 of 822) with videos related to

Pageof 83
Sort By:
BMJ (Clinical Research Ed.)|January 27, 1996
Association of Helicobacter pylori infection with coronary heart disease. Study shows association between H pylori infection and hypertensionG Y H Lip, R Wise, G Beevers
The Journal of Antimicrobial Chemotherapy|May 1, 1993
Comparison of 'E' test with conventional agar MICJ M Andrews, J E Bradley, R Wise
Antimicrobial Agents and Chemotherapy|November 1, 1992
In vitro activity of RU 29246, the active compound of the cephalosporin prodrug ester HR 916G Riess, J Andrews, D Thornber, et al.
Clinical Therapeutics|January 1, 1980
A study of the in vitro activity of cefoperazone: a comparison with other beta-lactam antibioticsR Wise, A P Gillett, J M Andrews
The Journal of Antimicrobial Chemotherapy|May 1, 1980
The pharmacokinetics of LY127935, a broad spectrum oxa-beta-lactamR Wise, S Baker, N Wright, et al.
The Journal of Antimicrobial Chemotherapy|February 1, 1985
The in-vitro activity of Ro 17-2301, a new monobactam, compared with other antimicrobial agentsR Wise, J M Andrews, L J Piddock
Antimicrobial Agents and Chemotherapy|June 1, 1986
In vitro activity of Ro 15-8074 and Ro 19-5247, two orally administered cephalosporin metabolitesR Wise, J M Andrews, L J Piddock
Antimicrobial Agents and Chemotherapy|August 4, 1998
Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniaeN P Brenwald, M J Gill, R Wise
Antimicrobial Agents and Chemotherapy|September 1, 1979
LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibioticsR Wise, J M Andrews, K A Bedford
Journal of Clinical Pathology|November 1, 1979
Interference of cefoxitin in the creatinine estimation and its clinical relevanceS R Durham, A H Bignell, R Wise
Pageof 83

Showing results (321-330 of 822) with videos related to

Sort By:
Pageof 83
BMJ (Clinical Research Ed.)|January 27, 1996
Association of Helicobacter pylori infection with coronary heart disease. Study shows association between H pylori infection and hypertensionG Y H Lip, R Wise, G Beevers
The Journal of Antimicrobial Chemotherapy|May 1, 1993
Comparison of 'E' test with conventional agar MICJ M Andrews, J E Bradley, R Wise
Antimicrobial Agents and Chemotherapy|November 1, 1992
In vitro activity of RU 29246, the active compound of the cephalosporin prodrug ester HR 916G Riess, J Andrews, D Thornber, et al.
Clinical Therapeutics|January 1, 1980
A study of the in vitro activity of cefoperazone: a comparison with other beta-lactam antibioticsR Wise, A P Gillett, J M Andrews
The Journal of Antimicrobial Chemotherapy|May 1, 1980
The pharmacokinetics of LY127935, a broad spectrum oxa-beta-lactamR Wise, S Baker, N Wright, et al.
The Journal of Antimicrobial Chemotherapy|February 1, 1985
The in-vitro activity of Ro 17-2301, a new monobactam, compared with other antimicrobial agentsR Wise, J M Andrews, L J Piddock
Antimicrobial Agents and Chemotherapy|June 1, 1986
In vitro activity of Ro 15-8074 and Ro 19-5247, two orally administered cephalosporin metabolitesR Wise, J M Andrews, L J Piddock
Antimicrobial Agents and Chemotherapy|August 4, 1998
Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniaeN P Brenwald, M J Gill, R Wise
Antimicrobial Agents and Chemotherapy|September 1, 1979
LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibioticsR Wise, J M Andrews, K A Bedford
Journal of Clinical Pathology|November 1, 1979
Interference of cefoxitin in the creatinine estimation and its clinical relevanceS R Durham, A H Bignell, R Wise
Pageof 83